
    
      The prevalence of type 2 diabetes is increasing dramatically in the last decade in China.
      Hyperlipidemia is a comorbid condition in type 2 diabetes and increase the adverse health
      outcomes. Flax lignans, a phytoestrogen found in flaxseed is thought to be the compound
      responsible for cholesterol-lowering effect of flaxseed. Our purpose is to improving the
      lipid profile in type 2 diabetic patients with supplementation of flax lignans.
    
  